Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Novartis Investigative Site, Melbourne

Novartis Investigative Site, Leuven

Novartis Investigative Site, Taipei

Novartis Investigative Site, Marseille

Hillman Cancer Center, Pittsburgh

Novartis Investigative Site, Santiago de Compostela

Novartis Investigative Site, Milan

Novartis Investigative Site, Milan

Novartis Investigative Site, Brescia

Novartis Investigative Site, Madrid

Novartis Investigative Site, Málaga

Emory University School of Medicine-Winship Cancer Institute, Atlanta

Novartis Investigative Site, Essen

Novartis Investigative Site, Valencia

Novartis Investigative Site, Cologne

Novartis Investigative Site, Lyon

Uni Of TX MD Anderson Cancer Cntr, Houston

Novartis Investigative Site, Freiburg im Breisgau

Novartis Investigative Site, Villejuif

Novartis Investigative Site, Beijing

Novartis Investigative Site, Singapore

Novartis Investigative Site, Singapore

Novartis Investigative Site, Guangzhou

Novartis Investigative Site, Hong Kong

Massachusetts General Hospital Cancer Center, Boston

Novartis Investigative Site, Montreal

Novartis Investigative Site, Copenhagen

Novartis Investigative Site, Dresden

Novartis Investigative Site, Nagoya

Novartis Investigative Site, Kashiwa

Novartis Investigative Site, Osaka

Novartis Investigative Site, Chuo Ku

Novartis Investigative Site, Koto Ku

Novartis Investigative Site, Amsterdam

Novartis Investigative Site, Seoul

Novartis Investigative Site, Barcelona

Novartis Investigative Site, L'Hospitalet de Llobregat